Global Carboxy Therapy Market

Carboxy Therapy Market size was valued at USD 101.36 Million in 2024 and the total Carboxy Therapy revenue is expected to grow at a CAGR of 12% from 2025 to 2032, reaching nearly USD 250.96 Million

Carboxy Therapy Market Overview

Carboxytherapy is a non-surgical treatment used to treat and improve the appearance of cellulite, stretch marks, and dark under-eye circles. This treatment is less invasive than other treatments used for cellulite reduction. Carboxytherapy treatment works by introducing a controlled amount of CO2 intradermally or subcutaneously.

Carboxy therapy treatments in the market are used on the skin with carbon dioxide to reduce fine lines, wrinkles, cellulite, and stretch marks, without requiring surgery. It leads the body to produce collagen, which renews and lifts the skin on its own. Rising earnings in emerging countries and new advancements in injection methods lead the market to grow. Issues such as pricey treatments, low awareness in certain places, and the International Society of Aesthetic Plastic Surgery’s 2024 data show there was a rise in worldwide face and head procedures. These procedures experienced a growth rate of approximately 14.8% from the previous year, reaching a total of 5,211,933 procedures globally.

The aesthetic clinics segment held the maximum market revenue share in 2024, due to the growing preference for aesthetic clinics & their cost-effectiveness. The North America region dominated the global market, owing to a rise in geriatrics and a rise in preference for minimally invasive procedures. The global key market players include DTA Medical, Mezopharma, MBE Medical Divisions, Alvi Prague, Kastner-Praxisbedarf, Beijing Jontelaser, and Cosmopro.To know about the Research Methodology :- Request Free Sample Report

Carboxy Therapy Market Dynamics

Increasing Aesthetic Plastic Surgery to Drive Market Growth

The increasing demand for plastic surgery is helping the carboxytherapy market to grow. More people looking for non-invasive cosmetic options have found carboxytherapy to be effective for improving the appearance of cellulite, the skin, and reducing localized fat. The number of aesthetic and cosmetic procedures has gone up by 19.3% worldwide, as revealed by the Society of Aesthetic Plastic Surgery (ISAPS). The procedures that surgeons perform most often are those outside of actual surgery.

High Treatment Costs, Limited Awareness, and Rising Alternative Treatment Create Restraints in the Carboxy Therapy Market

Lack of awareness, expensive treatments, and doubts about whether the therapy is adequate may hold back its expansion. Another factor is that more people try alternative treatments, like dermal fillers and laser therapies, so Carboxy Therapy could face more competition. Although these problems exist, the industry is benefiting from increases in aesthetic self-care and the popularity of light procedures, making its future very promising.

Carboxy Therapy Market Segment Analysis

Based on Product Type carboxy therapy market is segmented into tabletop and portable. Among them, the tabletop is expected to dominate the market in 2024 and is expected to hold the largest market share over the forecast period. Lots of these gadgets have easy-to-use interfaces and can fit on various digital platforms, letting paediatricians check and handle children’s medical issues remotely. Many people are using these devices because they let paediatric specialists offer constant and top-quality care to kids who live in underserved regions.

Based on Applications carboxy therapy market is segmented into Aesthetic medicine., Gynaecology, Angiology, Orthopaedics and rheumatology, Sports medicine, Others. Among them, the Aesthetic Medicine Segment has dominated in 2024 and is expected to hold the largest market share over the forecast period. The use of carboxy therapy in cosmetics, treating cellulite, stretch marks, and dark circles, causes many patients to look for it as a non-invasive choice. The increased acceptance by patients and healthcare staff, along with a high rate of patient happiness, helps increase its popularity.

Based on the End-User carboxy therapy market is segmented into Hospitals, Aesthetic clinics, and MedSpa. Aesthetic clinics are expected to dominate the market in 2024 and are expected to hold the largest market share over the forecast period. Cheaper treatment options and the ability to get cosmetic surgery supervised by a licensed doctor are why this segment has seen growth. Following carboxy therapy in an aesthetic clinic needs a time of 15-30 minutes, and people have to return every three to six months, making the market for these treatments grow.

Carboxy Therapy Market Regional Insights

Rising Consumer Demand and Interest Create North America Dominance in the Carboxy Therapy Market

A big market in the United States, Americans’ generous spending on fashion procedures, and the region’s progress in medicine and technology, Carboxy therapy is well accepted in the US because the demand for non-surgical procedures is increasing, people have money to invest, and there is strong marketing support. Since the population has a high income, they can pay for more cosmetic treatments, which leads to the rise of this procedure. Besides, more and more U.S. residents are getting older, and this trend is expected to increase. Due to aging, people often experience more wrinkles, fine lines, and dry skin. Thus, these are the main consumers that drive the market.

Carboxy Therapy Market Competitive Landscape

DTA Medical has been actively innovating, launching products like the "Carbo2 HP," a trolley-mounted carboxytherapy unit, emphasizing precision and user-friendliness. Similarly, Cosmopro introduced its "DIOX" system in 2020, focusing on advanced features like automated calibration and intelligent gas monitoring. While specific merger/acquisition news for other listed companies in the carboxytherapy domain isn't readily available, the trend is towards technological advancements (portable devices, automated systems), expanding applications beyond aesthetics, and strategic partnerships to maintain or grow market share against broader aesthetic solutions.

Carboxy Therapy Market Competitive Analysis

Companies such as DTA Medical, Cosmopro, and MBE Medical lead in carboxytherapy by adding features that lower pain and automation to their devices. The company is expecting substantial income in 2024 from broad business activities. At Alvi Prague, people don’t need needles, and the merger between Kastner and Hänsler in 2022 gave the latter a larger market and the chance to earn more, adding more innovative products and services. Beijing Jontelaser Technologies, representing an Asian manufacturing powerhouse, competes by offering a range of carboxytherapy machines, likely with a focus on competitive pricing and addressing the burgeoning demand in the Asian market. Their broader aesthetic device portfolio (cryolipolysis, fractional CO2 lasers) allows for a diversified revenue stream.

The general trend among these companies is towards technological refinement (e.g., increased precision, automated features, improved patient comfort like needle-free options), expanding the range of treatable conditions, and strategic maneuvers (mergers, new market entries) to solidify their positions in the growing non-invasive aesthetic market.

Carboxy Therapy  Market Scope: Inquire before buying

Carboxy Therapy Market by Region

North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Philippines, Malaysia, Vietnam, Thailand, ASEAN, and the Rest of APAC)
Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A)
South America (Brazil, Argentina, Rest of South America)

Carboxy Therapy Market key players are:

North America
1. Carboxytherapy America (USA)
2. BodyHT (USA)
3. Aesthetic Group (USA) RevitaLaze (Canada)
4. JMBIOTECH CO., LTD.

Europe
1. DTA Medical (Italy)
2. Mezopharma (Poland)
3. MBE Medical Divisions (Italy)
4. Alvi Prague (Czech Republic)
5. Kastner-Praxisbedarf / Hänsler Medical Group (Germany)

Asia Pacific
1. Beijing Jontelaser Technologies Co., Ltd. (China)
2. Cosmopro (South Korea)
3. JMBIOTECH CO., LTD. (South Korea)
4. DermAesthetic Co., Ltd. (Thailand)
5. Pyramid Farma (Indonesia)

South America
1. Dermavan SAS (Colombia)
2. Beautytek (Brazil)
3. La femme
4. Medpro Equipment (Brazil)
5. Biocare (Chile)

Middle East and Africa
1. SILKOR (Lebanon)
2. Rodana International (Saudi Arabia)
3. Homl Company / AL-MAZER Medical Group (Iraq)
4. Cocoon Medical (Spain)
5. DTA Medical (Italy)

Frequently Asked Questions:

1. What are the growth drivers for the Carboxy Therapy market?
Ans. Rising demand for non-invasive aesthetic and therapeutic procedures, coupled with increasing consumer awareness and technological advancements.

2. What are the major challenges for the Carboxy Therapy market growth?
Ans. High treatment costs, the need for extensive clinician education, varying regulatory hurdles across regions, and intense competition.

3. Which region is expected to lead the global Ethanolamines market during the forecast period?
Ans. North America is expected to lead the global ethanolamines market during the forecast period.

4. What is the projected market size & and growth rate of the Carboxy Therapy Market?
Ans. The Ethanolamines Market size was valued at USD 101.36 Mn. in 2024, and the total Ethanolamines Market revenue is expected to grow at a CAGR of 12% from 2024 to 2032, reaching nearly USD 250.96 Mn.

5. What segments are covered in the Carboxy Therapy Market report?
Ans. The segments covered in the Carboxy therapy market report are Product Type, Application, and End-use.